Literature DB >> 28514687

Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach.

Paola Martinez-Murillo1, Karen Tran2, Javier Guenaga2, Gustaf Lindgren3, Monika Àdori1, Yu Feng2, Ganesh E Phad1, Néstor Vázquez Bernat1, Shridhar Bale2, Jidnyasa Ingale2, Viktoriya Dubrovskaya2, Sijy O'Dell4, Lotta Pramanik1, Mats Spångberg5, Martin Corcoran1, Karin Loré3, John R Mascola4, Richard T Wyatt6, Gunilla B Karlsson Hedestam7.   

Abstract

The development of soluble envelope glycoprotein (Env) mimetics displaying ordered trimeric symmetry has ushered in a new era in HIV-1 vaccination. The recently reported native, flexibly linked (NFL) design allows the generation of native-like trimers from clinical isolates at high yields and homogeneity. As the majority of infections world-wide are of the clade C subtype, we examined responses in non-human primates to well-ordered subtype C 16055 trimers administered in soluble or high-density liposomal formats. We detected superior germinal center formation and enhanced autologous neutralizing antibodies against the neutralization-resistant (tier 2) 16055 virus following inoculation of liposome-arrayed trimers. Epitope mapping of the neutralizing monoclonal antibodies (mAbs) indicated major contacts with the V2 apex, and 3D electron microscopy reconstructions of Fab-trimer complexes revealed a horizontal binding angle to the Env spike. These vaccine-elicited mAbs target the V2 cap, demonstrating a means to accomplish tier 2 virus neutralization by penetrating the dense N-glycan shield.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cell responses; HIV-1; clade C; envelope glycoproteins; epitope; germinal centers; liposome; monoclonal antibody; trimers; vaccine

Mesh:

Substances:

Year:  2017        PMID: 28514687      PMCID: PMC5528178          DOI: 10.1016/j.immuni.2017.04.021

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  46 in total

1.  IMGT, the international ImMunoGeneTics database.

Authors:  M P Lefranc; V Giudicelli; C Ginestoux; J Bodmer; W Müller; R Bontrop; M Lemaitre; A Malik; V Barbié; D Chaume
Journal:  Nucleic Acids Res       Date:  1999-01-01       Impact factor: 16.971

2.  High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site.

Authors:  Christopher Sundling; Yuxing Li; Nick Huynh; Christian Poulsen; Richard Wilson; Sijy O'Dell; Yu Feng; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  Sci Transl Med       Date:  2012-07-11       Impact factor: 17.956

3.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

4.  Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2.

Authors:  Hua-Xin Liao; Mattia Bonsignori; S Munir Alam; Jason S McLellan; Georgia D Tomaras; M Anthony Moody; Daniel M Kozink; Kwan-Ki Hwang; Xi Chen; Chun-Yen Tsao; Pinghuang Liu; Xiaozhi Lu; Robert J Parks; David C Montefiori; Guido Ferrari; Justin Pollara; Mangala Rao; Kristina K Peachman; Sampa Santra; Norman L Letvin; Nicos Karasavvas; Zhi-Yong Yang; Kaifan Dai; Marie Pancera; Jason Gorman; Kevin Wiehe; Nathan I Nicely; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Faruk Sinangil; Jerome H Kim; Nelson L Michael; Thomas B Kepler; Peter D Kwong; John R Mascola; Gary J Nabel; Abraham Pinter; Susan Zolla-Pazner; Barton F Haynes
Journal:  Immunity       Date:  2013-01-11       Impact factor: 31.745

5.  Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

Authors:  Nicole A Doria-Rose; Chaim A Schramm; Jason Gorman; Penny L Moore; Jinal N Bhiman; Brandon J DeKosky; Michael J Ernandes; Ivelin S Georgiev; Helen J Kim; Marie Pancera; Ryan P Staupe; Han R Altae-Tran; Robert T Bailer; Ema T Crooks; Albert Cupo; Aliaksandr Druz; Nigel J Garrett; Kam H Hoi; Rui Kong; Mark K Louder; Nancy S Longo; Krisha McKee; Molati Nonyane; Sijy O'Dell; Ryan S Roark; Rebecca S Rudicell; Stephen D Schmidt; Daniel J Sheward; Cinque Soto; Constantinos Kurt Wibmer; Yongping Yang; Zhenhai Zhang; James C Mullikin; James M Binley; Rogier W Sanders; Ian A Wilson; John P Moore; Andrew B Ward; George Georgiou; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris; Peter D Kwong; Lawrence Shapiro; John R Mascola
Journal:  Nature       Date:  2014-03-02       Impact factor: 49.962

6.  Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.

Authors:  Laura K Pritchard; Daniel I R Spencer; Louise Royle; Camille Bonomelli; Gemma E Seabright; Anna-Janina Behrens; Daniel W Kulp; Sergey Menis; Stefanie A Krumm; D Cameron Dunlop; Daniel J Crispin; Thomas A Bowden; Christopher N Scanlan; Andrew B Ward; William R Schief; Katie J Doores; Max Crispin
Journal:  Nat Commun       Date:  2015-06-24       Impact factor: 14.919

7.  Serverification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE).

Authors:  Sergey Lyskov; Fang-Chieh Chou; Shane Ó Conchúir; Bryan S Der; Kevin Drew; Daisuke Kuroda; Jianqing Xu; Brian D Weitzner; P Douglas Renfrew; Parin Sripakdeevong; Benjamin Borgo; James J Havranek; Brian Kuhlman; Tanja Kortemme; Richard Bonneau; Jeffrey J Gray; Rhiju Das
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

8.  Epitope mapping of conformational V2-specific anti-HIV human monoclonal antibodies reveals an immunodominant site in V2.

Authors:  Luzia M Mayr; Sandra Cohen; Brett Spurrier; Xiang-Peng Kong; Susan Zolla-Pazner
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

9.  A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Authors:  Rogier W Sanders; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Anila Yasmeen; Natalia de Val; Helen J Kim; Claudia Blattner; Alba Torrents de la Peña; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Marit J van Gils; C Richter King; Ian A Wilson; Andrew B Ward; P J Klasse; John P Moore
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

10.  HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization.

Authors:  Marjon Navis; Karen Tran; Shridhar Bale; Ganesh E Phad; Javier Guenaga; Richard Wilson; Martina Soldemo; Krisha McKee; Christopher Sundling; John Mascola; Yuxing Li; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  PLoS Pathog       Date:  2014-08-28       Impact factor: 6.823

View more
  55 in total

Review 1.  Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?

Authors:  P J Klasse; Gabriel Ozorowski; Rogier W Sanders; John P Moore
Journal:  Cell Host Microbe       Date:  2020-04-08       Impact factor: 21.023

2.  HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.

Authors:  Yimeng Wang; Sijy O'Dell; Hannah L Turner; Chi-I Chiang; Lin Lei; Javier Guenaga; Richard Wilson; Paola Martinez-Murillo; Nicole Doria-Rose; Andrew B Ward; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam; Yuxing Li
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

3.  Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses.

Authors:  Shridhar Bale; Geraldine Goebrecht; Armando Stano; Richard Wilson; Takayuki Ota; Karen Tran; Jidnyasa Ingale; Michael B Zwick; Richard T Wyatt
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

4.  Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity.

Authors:  Sebastian Ols; Lifei Yang; Elizabeth A Thompson; Pradeepa Pushparaj; Karen Tran; Frank Liang; Ang Lin; Bengt Eriksson; Gunilla B Karlsson Hedestam; Richard T Wyatt; Karin Loré
Journal:  Cell Rep       Date:  2020-03-24       Impact factor: 9.423

5.  Targeted selection of HIV-specific antibody mutations by engineering B cell maturation.

Authors:  Kevin O Saunders; Kevin Wiehe; Ming Tian; Priyamvada Acharya; Todd Bradley; S Munir Alam; Eden P Go; Richard Scearce; Laura Sutherland; Rory Henderson; Allen L Hsu; Mario J Borgnia; Haiyan Chen; Xiaozhi Lu; Nelson R Wu; Brian Watts; Chuancang Jiang; David Easterhoff; Hwei-Ling Cheng; Kelly McGovern; Peyton Waddicor; Aimee Chapdelaine-Williams; Amanda Eaton; Jinsong Zhang; Wes Rountree; Laurent Verkoczy; Mark Tomai; Mark G Lewis; Heather R Desaire; Robert J Edwards; Derek W Cain; Mattia Bonsignori; David Montefiori; Frederick W Alt; Barton F Haynes
Journal:  Science       Date:  2019-12-06       Impact factor: 47.728

6.  Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers.

Authors:  Talar Tokatlian; Benjamin J Read; Christopher A Jones; Daniel W Kulp; Sergey Menis; Jason Y H Chang; Jon M Steichen; Sudha Kumari; Joel D Allen; Eric L Dane; Alessia Liguori; Maya Sangesland; Daniel Lingwood; Max Crispin; William R Schief; Darrell J Irvine
Journal:  Science       Date:  2018-12-20       Impact factor: 47.728

7.  Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains.

Authors:  Reda Rawi; Lucy Rutten; Yen-Ting Lai; Adam S Olia; Sven Blokland; Jarek Juraszek; Chen-Hsiang Shen; Yaroslav Tsybovsky; Raffaello Verardi; Yongping Yang; Baoshan Zhang; Tongqing Zhou; Gwo-Yu Chuang; Peter D Kwong; Johannes P M Langedijk
Journal:  Cell Rep       Date:  2020-11-24       Impact factor: 9.423

8.  Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles.

Authors:  Sonu Kumar; Xiaohe Lin; Timothy Ngo; Benjamin Shapero; Cindy Sou; Joel D Allen; Jeffrey Copps; Lei Zhang; Gabriel Ozorowski; Linling He; Max Crispin; Andrew B Ward; Ian A Wilson; Jiang Zhu
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

9.  Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery.

Authors:  David Peterhoff; Stefanie Thalhauser; Jan M Sobczak; Mona O Mohsen; Christoph Voigt; Nicole Seifert; Patrick Neckermann; Alexandra Hauser; Song Ding; Quentin Sattentau; Martin F Bachmann; Miriam Breunig; Ralf Wagner
Journal:  Vaccines (Basel)       Date:  2021-06-11

10.  Vaccine nanodiscs plus polyICLC elicit robust CD8+ T cell responses in mice and non-human primates.

Authors:  Alireza Hassani Najafabadi; Zeynab Izadi Najaf Abadi; Marisa E Aikins; Kathryn E Foulds; Mitzi M Donaldson; Wenmin Yuan; Emeka B Okeke; Jutaek Nam; Yao Xu; Priyan Weerappuli; Taryn Hetrick; David Adams; Patrick A Lester; Andres M Salazar; Dan H Barouch; Anna Schwendeman; Robert A Seder; James J Moon
Journal:  J Control Release       Date:  2021-07-16       Impact factor: 11.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.